Winn Funded Research
Reinero, C. R., L. A. Cohn, et al. (2008). “Adjuvanted rush immunotherapy using CpG oligodeoxynucleotides in experimental feline allergic asthma.” Vet Immunol Immunopathol 121(3-4): 241-50.
Asthma is one of the most common types of lung disease in cats, and can be debilitating or occasionally fatal. There is no cure for this disease, and treatment often relies on high doses of steroids given for the remainder of the cat’s life. Some cats become refractory to the effects of steroids and can develop life-threatening asthma attacks. In humans with life threatening allergies, a treatment option called rush immunotherapy (RIT) may be employed to attempt to quickly desensitize the patient to the allergen.
For more information:
Feline Asthma